Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery

Autor: Weeber, Fleur, Ooft, Salo N., Dijkstra, Krijn K., Voest, Emile E.

Publikováno v: In Cell Chemical Biology 21 September 2017 24(9):1092-1100

Codon-specific KRASmutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Autor: van de Haar, Joris, Ma, Xuhui, Ooft, Salo N., van der Helm, Pim W., Hoes, Louisa R., Mainardi, Sara, Pinato, David J., Sun, Kristi, Salvatore, Lisa, Tortora, Giampaolo, Zurlo, Ina Valeria, Leo, Silvana, Giampieri, Riccardo, Berardi, Rossana, Gelsomino, Fabio, Merz, Valeria, Mazzuca, Federica, Antonuzzo, Lorenzo, Rosati, Gerardo, Stavraka, Chara, Ross, Paul, Rodriquenz, Maria Grazia, Pavarana, Michele, Messina, Carlo, Iveson, Timothy, Zoratto, Federica, Thomas, Anne, Fenocchio, Elisabetta, Ratti, Margherita, Depetris, Ilaria, Cergnul, Massimiliano, Morelli, Cristina, Libertini, Michela, Parisi, Alessandro, De Tursi, Michele, Zanaletti, Nicoletta, Garrone, Ornella, Graham, Janet, Longarini, Raffaella, Gobba, Stefania Maria, Petrillo, Angelica, Tamburini, Emiliano, La Verde, Nicla, Petrelli, Fausto, Ricci, Vincenzo, Wessels, Lodewyk F. A., Ghidini, Michele, Cortellini, Alessio, Voest, Emile E., Valeri, Nicola

Publikováno v: Nature Medicine; March 2023, Vol. 29 Issue: 3 p605-614, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe.

Autor: Öner D; Translational Biomarkers Infectious Diseases & Statistics, Janssen Research & Development, Beerse, Belgium., Vernhes C; Vaccines R&D, Sanofi, Lyon, France., Balla-Jhagjhoorsingh S; Clinical Immunology, Janssen Vaccines and Prevention BV, Leiden, Netherlands., Moureau A; Vaccines R&D, Sanofi, Lyon, France., Crabbe M; Translational Biomarkers Infectious Diseases & Statistics, Janssen Research & Development, Beerse, Belgium., Salaun B; Vaccines R&D, GlaxoSmithKline (GSK), Rixensart, Belgium., Bastian AR; Clinical Immunology, Janssen Vaccines and Prevention BV, Leiden, Netherlands., Thys K; Translational Biomarkers Infectious Diseases & Statistics, Janssen Research & Development, Beerse, Belgium., De Smedt J; Vaccines R&D, GlaxoSmithKline (GSK), Rixensart, Belgium., Ooft SN; Clinical Immunology, Janssen Vaccines and Prevention BV, Leiden, Netherlands., Korsten K; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centre, Amsterdam University, Amsterdam, Netherlands., Adriaenssens N; Department of Primary and Interdisciplinary Care (ELIZA)-Centre for General Practice, University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium., Coenen S; Department of Primary and Interdisciplinary Care (ELIZA)-Centre for General Practice, University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Verheij TJM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands., Drysdale SB; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.; Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom., Wildenbeest JG; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Openshaw PJM; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Aerssens J; Translational Biomarkers Infectious Diseases & Statistics, Janssen Research & Development, Beerse, Belgium.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 18; Vol. 15, pp. 1448578. Date of Electronic Publication: 2024 Oct 18 (Print Publication: 2024).